HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip R Hamann Selected Research

Philip R Hamann Research Topics

Disease

9Neoplasms (Cancer)
06/2011 - 01/2002
4B-Cell Lymphoma (Lymphoma, B Cell)
07/2007 - 03/2004
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2006 - 01/2002
2Carcinoma (Carcinomatosis)
03/2005 - 07/2004
2Leukemia
01/2002 - 01/2002
1Lung Neoplasms (Lung Cancer)
06/2011
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2006
1Arthritis (Polyarthritis)
10/2005
1Breast Neoplasms (Breast Cancer)
03/2005
1Paralysis (Palsy)
12/2004

Drug/Important Bio-Agent (IBA)

10CalicheamicinsIBA
07/2007 - 01/2002
6Immunoconjugates (Immunoconjugate)IBA
06/2011 - 03/2004
5AntigensIBA
06/2011 - 07/2004
4Anti-Bacterial Agents (Antibiotics)IBA
03/2005 - 01/2002
3Gemtuzumab (Mylotarg)FDA Link
03/2006 - 01/2002
3Inotuzumab OzogamicinIBA
01/2006 - 03/2004
2Rituximab (Mabthera)FDA Link
07/2007 - 01/2006
2AmidesIBA
03/2005 - 03/2005
2CarbohydratesIBA
03/2005 - 01/2002
2HydrazinesIBA
07/2004 - 03/2004
1AcidsIBA
07/2007
1Cytotoxins (Cytolysins)IBA
07/2007
1Immunoglobulins (Immunoglobulin)IBA
03/2006
1Collagen Type II (Type II Collagen)IBA
10/2005
1Immunoglobulin G (IgG)IBA
03/2005
1hCTMO1-calicheamicinIBA
03/2005
1Monoclonal AntibodiesIBA
03/2005
1Cisplatin (Platino)FDA LinkGeneric
03/2005
1hu3S193-N-acetyl gamma calicheamicin dimethyl hydrazideIBA
07/2004
1Pharmaceutical PreparationsIBA
07/2004
1Lewis Y antigenIBA
07/2004
1DNA (Deoxyribonucleic Acid)IBA
03/2004

Therapy/Procedure

3Drug Therapy (Chemotherapy)
07/2007 - 03/2004
1Therapeutics
03/2006
1Injections
12/2004